pharma · No medical condition. · Generalized Myasthenia Gravis
Anaxis Pharma
Lacuna Pharma Pty Ltd
Lacuna Pharma Pty is a pharma organization headquartered in Colmenar Viejo, AU. Primary therapeutic focus areas include No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial
Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 2017
- Employees
- 7
- Programs
- 642
- Drugs
- 673
- Patents
- 0
NXP800 in subjects with Ovarian Cancer
Phase 1 · other · Platinum-resistant, ARID1a-mutated ovarian, fallopian tube and primary peritoneal carcinoma
NXP800 in subjects with Ovarian Cancer for Platinum-resistant, ARID1a-mutated ovarian, fallopian tube and primary peritoneal carcinoma is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code NXP800-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lacuna Pharma Pty Ltd
- Phase
- Phase 1
- Modality
- other
- Indication
- Platinum-resistant, ARID1a-mutated ovarian, fallopian tube and primary peritoneal carcinoma
- Status
- active
- Trials
- 1